ONL Therapeutics trials ONL1204 to treat retinal detachment
ONL1204 is designed to protect important retinal cells such as photoreceptors from cell death, which leads to vision loss and blindness. Credit: Karen Roe.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more